News

HCV drugs sofosbuvir, daclatasvir show promise as potential COVID-19 treatment

Using hepatitis C drugs sofosbuvir and daclatasvir in combination with standard care to treat patients with COVID-19 resulted in better 14-day recovery rates and a shorter hospital stay, according to data presented at AIDS 2020.“Laboratory studies have shown that daclatasvir has antiviral activity against SAR-CoV-2 and penetrates well into the lungs where COVID-19 infection can…

News

FDA approves Hulio, sixth Humira biosimilar

The FDA has approved the sixth biosimilar to adalimumab, adalimumab-fkjp, for all eligible indications of the biologic product, according to a company press release.Hulio (adalimumab-fkjp, Mylan/Fujifilm Kyowa Kirin), a biosimilar to Humira (adalimumab, AbbVie), is a TNF inhibitor intended to treat patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease,…

News

Google trends of GI symptoms may be ‘harbinger’ of COVID-19

Analysis of Google search trends correlated with increases in COVID-19 cases several weeks before any actual spike, according to study results.Kyle Staller, MD, MPH, of the division of gastroenterology at Massachusetts General Hospital, told Healio Gastroenterology that search data have previously been linked with seasonal influenza epidemics, so he and his colleagues applied the same…

News

The ‘Strange Fruit’ that haunts my days and dreams as a Black physician

Billie Holiday recorded “Strange Fruit” in 1937.“Southern trees bear a strange fruit Blood on the leaves and blood at the root Black bodies swinging in the southern breeze Strange fruit hanging from the poplar trees”It is a beautifully sung protest of a deeply inhumane American legacy of racism — lynching. Imagine, only in 2020, the…